Alnylam Pharmaceuticals (ALNY)

Add to Watchlists Create an Alert
53.32 -1.51  -2.75% NASDAQ Jul 28, 4:59PM BATS Real time Currency in USD
View Full Chart
ALNY Price Chart
View All Events

ALNY Events

Date Type Description
05/08/2014 16:30 EDT Misc Alnylam Pharmaceuticals Inc 1Q2014 Earning Conference Call
05/08/2014 Earnings Alnylam Pharmaceuticals Inc 1Q2014 Earning Result. Estimate: -1.18.
02/13/2014 16:30 EDT Misc Alnylam Pharmaceuticals, Inc. Q4 2013 Earning Conference Call
02/13/2014 Earnings Alnylam Pharmaceuticals, Inc. Q4 2013 Earning Result. Estimate: -0.48.
01/12/2014 Misc Alnylam Acquires Investigational Rnai Therapeutic Assets From Merck
11/06/2013 16:30 EST Misc Alnylam to Webcast Conference Call Discussing Third Quarter 2013 Financial Results
11/06/2013 Earnings Alnylam Q3 2013 Release. Estimate: -0.38.
08/08/2013 16:30 EDT Misc Alnylam to Webcast Conference Call Discussing Second Quarter 2013 Financial Results
08/08/2013 Earnings Second Quarter 2013 Financial Results. Estimate: -0.34.
View All Performance Charts

ALNY Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Alnylam Pharmaceuticals is up 18.49% over the last year vs S&P 500 Total Return up 19.54%, Arrowhead Research up 265.5%, and RXi Pharmaceuticals down 50.50%.

Get Quote for

PDF Report for ALNY

Download Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.

Download ALNY Pro Report PDF
Advertisement

Portfolio Strategies Featuring ALNY

Did Alnylam Pharmaceuticals make it into our Portfolio Strategies?
Start your YCharts membership now to find out.

ALNY Profile

  • Sector: Healthcare
  • Industry: Biotechnology
  • Company Website: http://www.alnylam.com
  • IR Website: http://investors.alnylam.com/index.cfm
  • HQ Country: United States
  • HQ State/Province: Massachusetts
  • Incorporation Country: United States
  • Incorporation State/Province: Delaware
  • Est. Current Fiscal Quarter End: June 30, 2014
  • Est. Current Fiscal Year End: December 31, 2014
  • Last Fiscal Quarter End: March 31, 2014
  • Last Fiscal Year End: December 31, 2013
  • NAICS: Pharmaceutical Preparation Manufacturing
  • NAICS Code: 325412
  • NAICS Industry: Pharmaceutical and Medicine Manufacturing
  • NAICS Sector: Manufacturing

Alnylam Pharmaceuticals Inc is a biopharmaceutical company developing novel therapeutics based on RNA interference, or RNAi.

ALNY Excel Add-In Codes

  • Name: =YCI("ALNY","name")
  • Description: =YCI("ALNY","description")
  • Sector: =YCI("ALNY","sector")
  • Industry: =YCI("ALNY","industry")
  • Est. Current Fiscal Year End: =YCI("ALNY","fye")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

required
required
required
required
required
Get Started Now
document.write('');

{{root.upsell.info.feature_headline}}.
Upgrade to {{root.upsell.info.tier_name}}. Start your {{root.upsell.info.tier_name}} Membership

{{root.upsell.info.feature_description}}

{{root.upsell.info.is_upgrade ? "Upgrade Now" : "Start My Free Trial"}}

Already a {{root.upsell.info.tier_name}} Member? Sign in here.